China Health Management Corp.: Installation of First Olympus Minimally Invasive Operating Theatre at the Richland International

LAS VEGAS, NEVADA (PINK SHEETS: CNHC) China Health Management Inc., a leading independent healthcare service provider in the People's Republic of China, today announced its Richland International Hospitals co-operation with Olympus for the first Minimally Invasive Olympus Operating Theatre in China will be completed and be operational in July.

After reaching the co-operative agreement stage project managers and technical experts from Olympus arrived at Richland International Hospital to over see the installation, the equipment and devices were imported from Japan as this is the first Olympus Minimally Invasive Operating Theatre in China. Olympus has sent out related engineers and their designers from Japan as well as local staff from their Shanghai Corporation office.

Olympus's Minimally Invasive Operating Theatre is a state of the art medical technology. With minimally invasive surgery, patients can recover quickly at the postoperative stage and be discharged from the hospital much earlier due to lesser amounts of surgical trauma and postoperative wound pain, it also decreases surgical scars, blood loss and wound infection.

Minimally invasive surgery has come into wide use during surgical procedures in a variety of clinical disciplines, including general surgery, ear, nose and throat surgery, urology, neuro-surgery, pediatric and thoracic surgery.

About China Health Management Corp.

China Health Management Corp. is a healthcare management company focused on Operations and Management of hospitals in China. The company's first target is to become the leader in the high-end healthcare and medical services industry in Kunming city, Yunnan Province, China.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained herein which are not historical are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays beyond the company's control with respect to market acceptance of new technologies or products, delays in testing and evaluation of products, and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission.

Contacts: China Health Management Corp. Investor Relations [phone] Email: [e-mail] Website: www.chinahealthcorp.com